pleuromutilins (Nabriva)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namepleuromutilins (Nabriva)
Drug Alias NameBC-3004BC-3080BC-3291
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial proteins synthesis inhibitors
TargetsBacterial proteins
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNabriva Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNabriva Therapeutics Ag
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A